cgp 42112a has been researched along with Stroke in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callaway, JK; McCarthy, CA; Vinh, A; Widdop, RE | 1 |
| Tsuda, K | 1 |
| Broughton, BR; Callaway, JK; McCarthy, CA; Sobey, CG; Vinh, A; Widdop, RE | 1 |
| Dorrance, AM | 1 |
4 other study(ies) available for cgp 42112a and Stroke
| Article | Year |
|---|---|
Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke.
Topics: Animals; Blood Pressure; Cell Survival; Cerebral Infarction; Consciousness; Disease Models, Animal; Immunohistochemistry; Injections, Intraventricular; Male; Motor Activity; Neuroprotective Agents; Oligopeptides; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Stroke; Superoxides; Vasodilator Agents | 2009 |
Angiotensin AT2 receptor-mediated neuroprotection and nitric oxide-bioavailability in stroke.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Biological Availability; Disease Models, Animal; Imidazoles; Membrane Fluidity; Nitric Oxide; Nitric Oxide Synthase Type III; Oligopeptides; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Stroke | 2009 |
Angiotensin II type 2 receptor stimulation initiated after stroke causes neuroprotection in conscious rats.
Topics: Animals; Apoptosis; Blood Pressure; Brain Ischemia; Cell Survival; Male; Motor Activity; Neuroprotective Agents; Oligopeptides; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Recovery of Function; Stroke | 2012 |
Angiotensin II type 2 receptor agonists as therapies for ischemic stroke.
Topics: Animals; Brain Ischemia; Male; Neuroprotective Agents; Oligopeptides; Receptor, Angiotensin, Type 2; Stroke | 2012 |